Works matching AU Poruba, Martin
Results: 14
Fenofibrate Decreases Hepatic P-Glycoprotein in a Rat Model of Hereditary Hypertriglyceridemia.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00056
- By:
- Publication type:
- Article
Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0220377
- By:
- Publication type:
- Article
Beneficial Effect of Fenofibrate in Combination with Silymarin on Parameters of Hereditary Hypertriglyceridemia-Induced Disorders in an Animal Model of Metabolic Syndrome.
- Published in:
- Biomedicines, 2025, v. 13, n. 1, p. 212, doi. 10.3390/biomedicines13010212
- By:
- Publication type:
- Article
Improvement bioavailability of silymarin ameliorates severe dyslipidemia associated with metabolic syndrome.
- Published in:
- Xenobiotica, 2015, v. 45, n. 9, p. 751, doi. 10.3109/00498254.2015.1010633
- By:
- Publication type:
- Article
NON-HOMOGENEOUS DISSOLUTION OF DRUG AFFECTS THE QUALITY OF PARENTERAL TREATMENT.
- Published in:
- Acta Poloniae Pharmaceutica, 2019, v. 76, n. 2, p. 323, doi. 10.32383/appdr/99297
- By:
- Publication type:
- Article
Efficacy and analgesic use during the therapy of iatrogenic pneumothorax using Pleuralvent™ and Chest Tube (ASPIRATE): A randomised controlled trial protocol.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2020, v. 164, n. 2, p. 213, doi. 10.5507/bp.2020.008
- By:
- Publication type:
- Article
The Combination of Atorvastatin With Silymarin Enhances Hypolipidemic, Antioxidant and Anti-Inflammatory Effects in a Rat Model of Metabolic Syndrome.
- Published in:
- Physiological Research, 2021, v. 70, n. 1, p. 33, doi. 10.33549/physiolres.934587
- By:
- Publication type:
- Article
in vitro and in silico Studies of Interaction of Synthetic 2,6,9-Trisubstituted Purine Kinase Inhibitors BPA-302, BP-21 and BP-117 With Liver Drug-Metabolizing Cytochromes P450.
- Published in:
- Physiological Research, 2020, v. 69, p. S627, doi. 10.33549/physiolres.934611
- By:
- Publication type:
- Article
Adherence k léčbě u chronických plicních chorob se zaměřením na CHOPN.
- Published in:
- Klinická Farmakologie a Farmacie, 2024, v. 38, n. 1, p. 26, doi. 10.36290/far.2024.003
- By:
- Publication type:
- Article
In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11513, doi. 10.3390/ijms222111513
- By:
- Publication type:
- Article
Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 14, p. 7680, doi. 10.3390/ijms22147680
- By:
- Publication type:
- Article
Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4527, doi. 10.3390/ijms22094527
- By:
- Publication type:
- Article
The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 45, doi. 10.3390/pharmaceutics14010045
- By:
- Publication type:
- Article
Silymarin prevents acetaminophen-induced hepatotoxicity in mice.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0191353
- By:
- Publication type:
- Article